Dearborn Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,729
Closed -$278K 275
2025
Q4
$278K Buy
5,729
+180
+3% +$8.92K 0.01% 233
2025
Q3
$262K Hold
5,549
0.01% 235
2025
Q2
$268K Buy
5,549
+133
+2% +$6.8K 0.01% 231
2025
Q1
$300K Sell
5,416
-305
-5% -$16.5K 0.01% 207
2024
Q4
$276K Buy
5,721
+126
+2% +$6.41K 0.01% 225
2024
Q3
$322K Buy
5,595
+47
+0.8% +$2.54K 0.01% 219
2024
Q2
$269K Hold
5,548
0.01% 227
2024
Q1
$270K Buy
5,548
+285
+5% +$13.9K 0.01% 226
2023
Q4
$262K Sell
5,263
-1,174
-18% -$57.4K 0.01% 222
2023
Q3
$345K Buy
6,437
+125
+2% +$6.67K 0.01% 176
2023
Q2
$340K Sell
6,312
-155
-2% -$8.34K 0.01% 175
2023
Q1
$352K Buy
6,467
+137
+2% +$6.66K 0.01% 174
2022
Q4
$307K Buy
6,330
+16
+0.3% +$702 0.01% 191
2022
Q3
$240K Buy
6,314
+199
+3% +$8.87K 0.01% 221
2022
Q2
$306K Hold
6,115
0.01% 195
2022
Q1
$314K Buy
6,115
+207
+4% +$10.7K 0.01% 201
2021
Q4
$296K Buy
5,908
+268
+5% +$13.3K 0.01% 217
2021
Q3
$272K Buy
5,640
+20
+0.4% +$1.02K 0.01% 210
2021
Q2
$296K Hold
5,620
0.01% 207
2021
Q1
$278K Hold
5,620
0.01% 210
2020
Q4
$273K Hold
5,620
0.01% 213
2020
Q3
$282K Sell
5,620
-181
-3% -$9.32K 0.01% 189
2020
Q2
$296K Hold
5,801
0.02% 176
2020
Q1
$254K Hold
5,801
0.02% 187
2019
Q4
$291K Hold
5,801
0.01% 199
2019
Q3
$269K Hold
5,801
0.02% 188
2019
Q2
$251K Buy
+5,801
New +$247K 0.02% 180

Other funds holding SNY

Dearborn Partners's SNY Position: Q1 2026 in Review

Dearborn Partners sold out of Sanofi (SNY) in Q1 2026, closing a stake of 5,729 shares — an estimated $278K sold.

Dearborn Partners first reported a position in SNY in Q2 2019 and held it in 27 quarters. The position peaked at $352K in Q1 2023. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Dearborn Partners reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Dearborn Partners sold 5,729 Sanofi shares in Q1 2026, an estimated $278K.
  • Dearborn Partners first reported a position in Sanofi in Q2 2019 and held it in 27 quarters.
  • Dearborn Partners's Sanofi position peaked at $352K in Q1 2023.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.